See the program overview for the upcoming Cannabis Science Conference Fall in Providence, Rhode Island September 20-22nd.
Editor's Note: This agenda was accurate at the time of publication in early August 2023. Speaker names and specific time slots are subject to change.
Register here!
Day 1
Keynote
9:00 a.m.
Knowledge and Art of Combining Cannabinoids for Treatment Success
Speaker: Dr. Dustin Sulak, DO, Healer
FIRESIDE CHAT DISCUSSION, CULTIVATION FOCUS
10:00 a.m.
Industry Answers with Adam Jacques
Moderator: Zacariah Hildenbrand, PhD, Chief Technical Officer, ZED Therapeutics
Speaker: Adam Jacques, AgSense LLC Oregon
11:00 a.m. Coffee Break/Posters/Networking- Exhibit Hall
11:30 a.m.
Analytical Track: Is it the time to pay more attention to flavonoids in cannabis products
Speaker: Dr. Harry Behzadi, President and CEO of AccuScience Labs
11:30 a.m.
Medical Track: Unprescribed Film Screening
Speaker: Steve Ellmore, Filmmaker and veteran, The Unprescribed
11:30 a.m.
Psychedelics Track: Next Generation of Scientists Examining How to Mitigate Chronic Disease with Psychedelics
Moderator:Dr. Denise Vidot, University of Miami
Speakers: Brea-Necole Diggs, PhD Student, University of Miami - Miller School of Medicine; Dr. Amrit Baral, PhD Student, University of Miami - Miller School of Medicine; and Owen Berke, Student, University of Miami
11:50 a.m.
Analytical Track: Analysis of Cannabis Products for As, Cd, Hg, Pb by ICP-OES: Meeting the DL Challenge
Speaker: Sergei Leikin, Texas Scientific Products and Autumn Phillips, Inorganic Ventures
12:00 p.m.
Medical Track: Veterans Panel Discussion
Moderator: Cherissa Jackson, RN, WeDecode
Speakers: Steve Ellmore, Filmmaker and veteran, The Unprescribed; Ellen Brown, Founder; Green Path Training; Stephen Mandile, Veteran Advocate and Co-Founder, Cannabis Advancement Series; and Wayne Smith, Former Combat Medic
12:00 p.m.
Psychedelics Track: Preparation and Analysis of Psychoactive Alkaloids and Their Metabolites in Multiple Matrices
Speaker: Dan DeLurio, Business Development Manager, Restek
12:10 p.m.
Analytical Track: Cannabinoid Extraction Efficiency for Potency Analysis: An in Depth Look of Multiple Techniques
Speaker: Melinda Urich, Advanced Scientist, LC Solutions, Restek
12:30 p.m. LUNCH
1:30 p.m.
Analytical Track: Quality control in Cannabis microbiology: How to comply and go further than industry standard
Speaker: Anthony Repay, Laboratory Director, Method Testing Labs
1:30 p.m.
Medical Track: Exploring cannabinoid therapy as a safer alternative for dementia symptom management
Speaker: Blake Pearson, Co-Investigator, Pearson Health and Mikelle Bryson-Campbell, co-investigator
1:30 p.m.
Cultivation Track: The Updated Soil Food Web
Speaker: Jeff Lowenfels, Author: Teaming with Microbes Series, lord of the roots
1:50 p.m.
Analytical Track: The Curious Case of Cannabis: Understanding the Microbiology of Cannabis
Speaker: Patrick Bird, Sr. Manager Scientific Affairs, bioMerieux
2:00 p.m.
Cultivation Track: Microbial Consultation Guidelines for Common Reservoirs of Contamination in Cultivation Facilities
Speaker: Frankie Claunch, Microbiologist, PuEr Lab, LLC
2:00 p.m.
Medical Track:Patient Profiles: Characteristics of a large sample of medical cannabis patients
Speaker: Amanda Reiman, Chief Knowledge Officer, New Frontier Data
2:10 p.m.
Analytical Track: Group Q&A
Speakers: Anthony Repay, Laboratory Director, Method Testing Labs and Patrick Bird, Sr. Manager Scientific Affairs, bioMerieux
2:30p.m. Coffee Break/Posters/Networking- Exhibit Hall
3:00 p.m.
Analytical Track: Getting the Most Out of Analytical Testing
Speaker: Zacariah Hildenbrand, PhD, Chief Technical Officer, ZED Therapeutics
3:00 p.m.
Psychedelics Track: Barriers to and Learnings from Psychedelics Research
Moderator: Miyabe Shields, Founder, Scientist, Project Chronic
Panelists: Riley Kirk, PhD - Professor URI and Marné Garretson, MPH
3:00 p.m.
Medical Track: Panel Discussion: Clinical Directors - Navigating Legalization and Beyond
Speaker/Moderator: Laura Barrett-Nutting, Executive Director, National Clinical Director Consortium
Panelists: Dawn-Marie Steenstra, National Clinical Director Consortium, Clinical Director of Dispensaries; Dr. Travis Poonai, Clinical Director, Curaleaf; and Kevin Harbison, Manager of Clinical Services and Regulatory Operations, PharmaCan
3:20 p.m.
Analytical Track: Cannabis Testing: Current Needs and Approaches
Speaker: Dominika Gruszecka, Market Manager, Shimadzu Scientific Instruments
3:40 p.m.
Analytical Track: Pathogen Testing: Why, Where and How
Speaker: Scott Churchill, Vice President of Scientific Development, MCR Labs
4:00 p.m.
Analytical Track: Impacts of Plant Pathogens on Yield
Speaker: Maria McIntyre, Head of Cannabis, bioMérieux, Inc.
4:00 p.m.
Medical Track: Layered Microdosing of Cannabis for Health and Wellness
Speaker: Monica Werkheiser, Canna Remedies NJ, Operations Research Specialist and Clinical Cannabis Pharmacist
4:20 p.m. Analytical Track: Group Discussion/Q&A
4:30p.m.
Medical Track: Structure-based Cannabinoid and Psychedelic Drug Design
Speaker: Mike McCormick, Scientist, &x consulting LLC
5:00 p.m.
Poster Sessions and Opening Night Reception
Day 2
Keynote
9:00 a.m.
Cannabis Reconsidered: A Science-Based Look at the True Harms and Benefits
Speaker: Dr. Peter Grinspoon, MD, primary care doctor at Massachusetts General Hospital, Instructor in Medicine at Harvard Medical School
FIRESIDE CHAT DISCUSSION, ANALTICAL FOCUS
10:00 a.m.
Sample Preparation, Compound Error, and Potency Inflation
Speaker: Jini Glaros, Chief Scientific Officer, Modern Canna Labs
10:20 a.m.
The Art of Potency Plumping
Speaker: Christopher Hudalla, President/CSO, ProVerde Laboratories, Inc.
10:40 a.m.
General Session: Q&A
Speakers: Jini Glaros, Chief Scientific Officer, Modern Canna Labs and Christopher Hudalla, President/CSO, ProVerde Laboratories, Inc.
11:00 a.m. Coffee Break and Networking- Exhibit Hall
11:30 a.m.
Analytical Track:Risk Assessment & Toxicological Evaluation for Cannabis Terpene Concentrates Intended for Inhalation
Speaker: Willie McKinney, CEO, McKinney Regulatory Science Advisor LLC
11:30 a.m.
Medical Track: Panel Discussion: How do we educate our fellow healthcare providers?
Moderator: Brian Essenter, MM Consult CT
Panelists: Janice Newell Bissex, Program Director of Cannabinoid Medical Sciences, John Patrick University School of Integrative
and Functional Medicine; Uzma Zakir, RPh, founder of bloomHigher consulting; and Dr. Peter Grinspoon, MD
11:30 a.m.
Cultivation Track: The Impact of Light Distribution on Cannabis Sativa: Intercanopy vs Overhead Light with Equal DLIs
Speaker: Travis Higginbotham, VP of Cultivation, Statehouse Holdings
11:50 p.m.
Analytical Track: Diamonds, Decarboxylation, and Data: Post-Processing Demystified via Sensor Automation
Speakers: Corey Crosser, Mfg. Rep / Extraction & Operations Consultant Sample Automation and Thomas Rosengren, Founder, Masterkemist
12:00 p.m.
Medical Track: Cannabinoids for the Treatment of Agitation in Dementia
Speakers: Ryan Buck, MD, Northwestern University - Feinberg School of Medicine and Rebecca Abraham, CEO and Founder,Acute on Chronic
12:00 p.m.
Cultivation Track: Eliminate Viroids and Systemic Pathogens Using Fast Return Tissue Culture
Speaker: William Graham, Founder and President, Microclone Tissue Culture/Tangent Bioscience
12:10 p.m.
Analytical Track: More Easy Options Than You Think: Optimization Overview of Gas Chromatograph Inlet and Injection Parameters for Pesticide Residue Analysis in Cannabis
Speaker: Julie Kowalski, PhD, jkSS, LLC
12:30 p.m. LUNCH
1:30 p.m.
Analytical Track: LCMS Analysis of Phospholipids for the Degumming Optimization for Hemp/Cannabis Extracts
Speaker: Christopher Hudalla, President/CSO, ProVerde Laboratories, Inc.
1:30 p.m.
Medical Track: What if My Client Already Loves Cannabis? Managing Dual Rec & Med Users in Clinical Practice
Speaker: David Aronson, LCSW, Cannabis Educator
1:30 p.m.
Psychedelics Track: Psychedelic Asia: Integrating Ancient Asian Wisdom and Modern Science in The Mind Medicine
Speaker: Dr. Aimon Kopera, Geneomics Global
1:50 p.m.
Analytical Track: Improved Techniques and Methodology for Residual Solvent Analysis in Cannabis and Hemp Products
Speaker: Roy Sorensen, Senior Laboratory Director, Method Testing Labs
2:00 p.m.
Medical Track: Unveiling Cannabinoids' Potential: Cannabis for Managing Sleep Disorders
Speaker: Dr. Jeremy Riggle, Chief Manufacturing Officer, Day Three Labs
2:00 p.m.
Psychedelics Track: Breakdown of the FDA’s Guidance on Psychedelic Clinical Trials
Speaker: J. Preston Campbell, Vice President of Innovation, Venebio/Consilium Sciences
2:10 p.m.
Analytical Track: Compliance Testing and Truth in Labeling - A look at ASTM D8449
Speaker: Darwin Millard, Chief Science Officer, 14th Round/Final Bell
2:30 p.m.
Analytical Track: Standards and Accreditation – The Way We Move Forward?
Moderators: Evan Friedmann, Scientific Cell Company and Patricia Atkins, Antylia
Speakers: Allison Baker, AOAC INTERNATIONAL; Nandakumara D. Sarma, US Pharmacopeia; James Farrell, ASTM International; and Susan Audino, PhD, S. A. Audino & Associates, LLC
2:30 p.m.
Medical Track: Oropharyngolaryngeal Effects of Cannabis Smoking
Speaker: Dr. Dawn Clarke, Green Dentistry
2:30 p.m.
Cultivation Track: Improving Cultivation through Irrigation Automation
Speaker: Isadore Becker-Uncapher, Head of Research and Development, Sustainable Village
3:00 p.m.
Medical Track: Impact on clinical outcomes of multidisciplinary medicinal cannabis clinics on anxiety patients
Speaker: Bhumi Bhojak, Clinical Research Lead, Harvest Medicine, MediPharmlabs.com
3:00 p.m.
Cultivation Track: Control of Hop Latent Viroid in a Large Cannabis Cultivation Operation: Strategies and Observations
Speakers: Ulrich Reimann-Philipp, Director of Tissue Culture, Fluresh LLC
3:30 p.m.
Cultivation Track: Airflow Crop Steering for Cannabis Cultivation
Speakers: Jesse Porter, Director of Cultivation, Grow Glide
3:45 p.m. Adjourn
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.